Dexamethasone enhances CTLA-4 expression during T cell activation

Cellular and Molecular Life Sciences

Volumn 55, Issue 12, 1999, Pages 1649-1656

  Xia, M ^a   Gasser, J ^a   Feige, U ^a  

^a AMGEN INC   (United States)

Author keywords

CD28; Costimulation; CTLA 4; Dexamethasone; T cell

Indexed keywords

CD28 ANTIGEN; CONCANAVALIN A; CYCLOSPORIN A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DEXAMETHASONE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR; MESSENGER RNA; MIFEPRISTONE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD3; RAPAMYCIN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; FEMALE; GENE INDUCTION; IMMUNOBLOTTING; KINETICS; MOUSE; NONHUMAN; PROTEIN INDUCTION; RIBONUCLEASE PROTECTION ASSAY; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION; CELLS, CULTURED; DEXAMETHASONE; IMMUNOCONJUGATES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES;

EID: 0032828346     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050403     Document Type: Article

References (28)

1. Linsley P. S., Brady W., Grosmaire L., Aruffo A., Damle N. K. and Ladbetter J. A. (1991) Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173: 721-730
2. Thompson C. B., Lindsten T., Ledbetter J. A., Kunkel S. L., Young H. A., Emerson S. G. et al. (1989) CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc. Natl. Acad. Sci. USA 86: 1333-1337
3. Brunet J. F., Denizot F., Luciani M. F., Roux-Dosseto M., Suzan M., Mattei M. G. et al. (1987) A new member of the immunoglobulin super-family CTLA-4. Nature 328: 267-270
4. Dariavach P., Mattei M. G., Golstein P. and LeFranc M. P. (1988) Human Ig superfamily CTLA-4 gene: chromosomal localization and identify of protein sequence between murine and human CTLA-4 cytoplasmic domains. Eur. J. Immunol. 18: 1901-1905
5. Harper K., Balzano C., Rouvier F., Mattei M. G., Luciani M. F. and Golstein P. (1991) CTLA-4 and CD28 activated lymphocyte molecules arc closely related in both mouse and human as to sequence, message expression, gene structure and chromosomal location. J. Immunol. 147: 1037-1044
6. Freeman G. J., Lombard D. B., Gimmi C. D., Brod S. A., Lee K., Laning J. C. et al. (1992) CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production. J. Immunol. 149: 3795-3801
7. Linsley P. S., Greene J. L., Tan P., Bradshaw J., Ledbetter J. A., Anasetti C. et al. (1992) Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med. 176: 1595-1604
8. Krummel M. F. and Allison J. P. (1995) CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182: 459-465
9. Walunas T. L., Lenschow D. J., Bakker C. Y., Linsley P. S., Freeman G. J., Green J. M. et al. (1994) CTLA-4 can function us a negative regulator of T cell activation. Immunity 1: 405-413
10. Waterhonse P., Penninger J. M., Timms E., Wakeham A., Shahinian A., Lee K. P. et al. (1995) Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270: 985-988
11. Tivol E. A., Borriello F., Schweitzer A. N., Lynch W. P., Bluestone J. A. and Sharpe A. H. (1995) Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3: 541-547
12. Beato M. (1989) Gene regulation by steroid hormones. Cell 56: 335-344
13. Barnes P. J. and Adcock I. (1993) Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol. Sci. 14: 436-441
14. Furue M. and Ishibashi Y. (1991) Differential regulation by dexamethasone and cyclosporine of human T cells activated by various stimuli. Transplantation 52: 522-526
15. Paliogianni F., Ahuja S. S., Balow J. P. and Boumpas D. T. (1993) Novel mechanism for inhibition of human T cells by glucocorticoids. Glucocorticoids inhibit signal transduction through IL-2 receptor. J. Immunol. 151: 4081-4089
16. Cadepond F., Ulmann A. and Baulieu E. E. (1997) RU486 (mifepristone): mechanisms of action and clinical uses. Ann. Rev. Med. 48: 129-156
17. Alegre M. L., Noel P. J., Eisfelder B. J., Chuang E., Clark M. R., Reiner S. L. et al. (1996) Regulation of surface and intracellular expression of CTLA-4 on mouse T cells. J. Immunol. 157: 4762-4770
18. Lindsten T., Lee K. P., Harris E. S., Petryniak B., Craighead N., Reynolds P. J. et al. (1993) Characterization of CTLA-4 structure and expression on human T cells. J. Immunol. 151: 3489-3499
19. Boumpas D. T., Anastassiou E. D., Older S. A., Tsokos C. C., Nelson D. L. and Balow J. E. (1991) Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription. J. Clin. Invest. 87: 1739-1747
20. Ho S., Clipstone N., Timmermann L., Northrop J., Graef L., Fiorentino D. et al. (1996) The mechanism of action of cyclosporin A and FK506. Clin. Immunol. Immunopathol. 80: S40-45
21. Sigal N. H. and Dumont F. J. (1992) Cyclosporin A, FK-506 and rapamycin: pharmacologic probes of lymphocyte signal transduction. Annu. Rev. Immunol. 10: 519-560
22. Abraham R. T. and Wiederrecht G. J. (1996) Immunopharmacology of rapamycin. Annu. Rev. Immunol. 14: 483-510
23. Northrop J. P., Crabtree G. R. and Mattila P. S. (1992) Negative regulation of interleukin 2 transcription by the glucocorticoid receptor. J. Exp. Med. 175: 1235-1245
24. Hurwitz A. A., Sullivan T. J., Krummel M. F., Sobel R. A. and Allison J. P. (1997) Specific blockade of CTLA-4/B7 interactions results in exacerbated clinical and histologic disease in an actively-induced model of experimental allergic encephalomyelitis. J. Neuroimmunol. 73: 57-62
25. Fleischer J., Soeth E., Reiling N., Grage-Griebenow E., Flad H.-D. and Ernst M. (1996) Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood monocytes. Immunology 89: 592-598
26. Girndt M., Sester U., Kaul H., Hünger F. and Köhler H. (1998) Glucocorticoids inhibit activation-dependent expression of costimulatory molecule B7-1 in human monocytes. Transplantation 66: 370-375
27. Gause W. C., Halvorson M. J., Lu P., Greenwald R., Linsley P., Urban J. F. et al. (1997) The function of costimulatory molecules and the development of IL-4-producing T cells. Immunol. Today 18: 115-120
28. Kuchroo V. K., Das M. P., Brown J. A., Ranger A. M., Zamvil S. S., Sobel R. A. et al. (1995) B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80: 707-718